Opes Advisors’s Celgene CELG Stock Holding History
Bought
Maintained
Sold
Other funds holding CELG
Opes Advisors's CELG Position: Q4 2017 in Review
Opes Advisors sold out of Celgene (CELG) in Q4 2017, closing a stake of 13,374 shares — an estimated $1.95M sold.
Opes Advisors first reported a position in CELG in Q1 2017 and held it in 3 quarters. The position peaked at $1.95M in Q3 2017. 1,471 funds tracked by Wall St. Rank hold CELG as of Q4 2017.
- Opes Advisors reported no remaining Celgene position as of Q4 2017 after selling out during the quarter.
- Opes Advisors sold 13,374 Celgene shares in Q4 2017, an estimated $1.95M.
- Opes Advisors first reported a position in Celgene in Q1 2017 and held it in 3 quarters.
- Opes Advisors's Celgene position peaked at $1.95M in Q3 2017.
- 1,471 funds tracked by Wall St. Rank held Celgene as of Q4 2017.
Based on Opes Advisors's 13F filing for Q4 2017, filed 9 Feb 2018.